SP
JNJ icon

Symmetry Partners’s Johnson & Johnson JNJ Stock Holding History

Symmetry Partners’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16M Sell
8,497
-1,261
-13% -$294K 0.11% 62
2026
Q1 		$2.39M Buy
9,758
+1,096
+13% +$255K 0.14% 55
2025
Q4 		$1.79M Buy
8,662
+1,389
+19% +$275K 0.11% 61
2025
Q3 		$1.35M Buy
7,273
+797
+12% +$137K 0.15% 58
2025
Q2 		$989K Buy
6,476
+748
+13% +$115K 0.12% 65
2025
Q1 		$950K Buy
5,728
+757
+15% +$118K 0.13% 63
2024
Q4 		$719K Buy
4,971
+581
+13% +$90K 0.1% 74
2024
Q3 		$711K Sell
4,390
-14,877
-77% -$2.37M 0.17% 52
2024
Q2 		$2.82M Sell
19,267
-3,130
-14% -$466K 0.14% 66
2024
Q1 		$3.54M Hold
22,397
– – 0.28% 53
2023
Q4 		$3.51M Sell
22,397
-5,481
-20% -$840K 0.19% 59
2023
Q3 		$4.34M Buy
27,878
+1,244
+5% +$205K 0.24% 60
2023
Q2 		$4.41M Buy
26,634
+5,819
+28% +$939K 0.23% 59
2023
Q1 		$3.23M Sell
20,815
-7,108
-25% -$1.15M 0.18% 70
2022
Q4 		$4.93M Sell
27,923
-5,600
-17% -$967K 0.29% 49
2022
Q3 		$5.48M Buy
33,523
+2,270
+7% +$384K 0.37% 46
2022
Q2 		$5.55M Buy
31,253
+7,971
+34% +$1.42M 0.37% 43
2022
Q1 		$4.13M Sell
23,282
-955
-4% -$162K 0.26% 51
2021
Q4 		$4.15M Sell
24,237
-4,005
-14% -$656K 0.26% 50
2021
Q3 		$4.51M Buy
28,242
+3,067
+12% +$523K 0.3% 49
2021
Q2 		$4.15M Sell
25,175
-3,734
-13% -$618K 0.28% 59
2021
Q1 		$4.75M Sell
28,909
-4,601
-14% -$744K 0.34% 50
2020
Q4 		$5.27M Sell
33,510
-1,375
-4% -$203K 0.41% 41
2020
Q3 		$5.19M Buy
34,885
+22,387
+179% +$3.31M 0.44% 42
2020
Q2 		$1.76M Buy
+12,498
New +$1.82M 0.22% 57
2019
Q4 		– Sell
-12,785
Closed -$1.65M – 351
2019
Q3 		$1.65M Sell
12,785
-10,384
-45% -$1.37M 0.34% 42
2019
Q2 		$3.23M Buy
+23,169
New +$3.21M 0.66% 24

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Symmetry Partners's JNJ Position: Q2 2026 in Review

Symmetry Partners reduced its Johnson & Johnson (JNJ) stake by 13% in Q2 2026, selling an estimated $294K and leaving 8,497 shares worth $2.16M. The position accounts for 0.11% of the portfolio, ranked #62.

Symmetry Partners first reported a position in JNJ in Q2 2019 and has held it in 27 quarters since. The position peaked at $5.55M in Q2 2022. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Symmetry Partners held 8,497 shares of Johnson & Johnson worth $2.16M as of Q2 2026.
  • Symmetry Partners sold 1,261 Johnson & Johnson shares in Q2 2026, an estimated $294K.
  • Johnson & Johnson made up 0.11% of Symmetry Partners's portfolio in Q2 2026, its #62 holding.
  • Symmetry Partners first reported a position in Johnson & Johnson in Q2 2019 and has held it in 27 quarters since.
  • Symmetry Partners's Johnson & Johnson position peaked at $5.55M in Q2 2022.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Symmetry Partners's 13F filing for Q2 2026, filed 23 Jul 2026.